{"DataElement":{"publicId":"3623186","version":"1","preferredName":"Breast Carcinoma Neoplasm Singularity Status","preferredDefinition":"Text term to represent the occurrence pattern of a breast tumor.","longName":"3623180v1.0:3623182v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3623180","version":"1","preferredName":"Breast Carcinoma Neoplasm Singularity","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Not accompanied by another or others; exclusive of anyone or anything else.","longName":"3623177v1.0:3623178v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3623177","version":"1","preferredName":"Breast Carcinoma Neoplasm","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C4872:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-36AD-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3623178","version":"1","preferredName":"Single","preferredDefinition":"Not accompanied by another or others; exclusive of anyone or anything else. ","longName":"C48440","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-36BB-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-36CC-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3623182","version":"1","preferredName":"Neoplasm Singularity Status","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Not accompanied by another or others; exclusive of anyone or anything else._A condition or state at a particular time.","longName":"3623182v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ipsilateral tumors","valueDescription":"Ipsilateral Neoplasm","ValueMeaning":{"publicId":"3623183","version":"1","preferredName":"Ipsilateral Neoplasm","longName":"3623183","preferredDefinition":"Having to do with the same side of the body.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ipsilateral","conceptCode":"C25308","definition":"Having to do with the same side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-370A-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB812A5-3723-45C6-E040-BB89AD433803","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":">1 Quadrant","valueDescription":"Greater Than One Quadrant","ValueMeaning":{"publicId":"3623184","version":"1","preferredName":"Greater Than One Quadrant","longName":"3623184","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: One quarter of a circle. In anatomy, one part of an area divided into quarters for descriptive purposes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quadrant","conceptCode":"C61106","definition":"One quarter of a circle. In anatomy, one part of an area divided into quarters for descriptive purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-3731-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB812A5-374A-45C6-E040-BB89AD433803","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"1 Quadrant","valueDescription":"One Quadrant","ValueMeaning":{"publicId":"3623185","version":"1","preferredName":"One Quadrant","longName":"3623185","preferredDefinition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.: One quarter of a circle. In anatomy, one part of an area divided into quarters for descriptive purposes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quadrant","conceptCode":"C61106","definition":"One quarter of a circle. In anatomy, one part of an area divided into quarters for descriptive purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-3757-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB812A5-3770-45C6-E040-BB89AD433803","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"Solitary","valueDescription":"Single Neoplasm","ValueMeaning":{"publicId":"2991868","version":"1","preferredName":"Single Neoplasm","longName":"2991868","preferredDefinition":"Not accompanied by another or others.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9EC0-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB812A5-3784-45C6-E040-BB89AD433803","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"Multiple","valueDescription":"Multiple Tumors","ValueMeaning":{"publicId":"5241763","version":"1","preferredName":"Multiple Tumors","longName":"5241763v1.00","preferredDefinition":"A finding indicating the presence of more than two tumor masses in a single anatomic site or different anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Tumor Masses","conceptCode":"C39787","definition":"A finding indicating the presence of more than two tumor masses in a single anatomic site or different anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31DC44C0-D998-CA58-E050-BB89AD430BE2","latestVersionIndicator":"Yes","beginDate":"2016-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-02","modifiedBy":"KUMMEROA","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31DC44C0-D9B1-CA58-E050-BB89AD430BE2","beginDate":"2016-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-02","modifiedBy":"ONEDATA","dateModified":"2016-05-02","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30746FAB-E6B1-86D5-E050-BB89AD437F9E","beginDate":"2016-04-14","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-04-14","modifiedBy":"ONEDATA","dateModified":"2016-04-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3623181","version":"1","preferredName":"Neoplasm Single Status","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Not accompanied by another or others; exclusive of anyone or anything else. :A condition or state at a particular time.","longName":"C3262:C48440:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-36E1-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB812A5-36F2-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"KUMMEROA","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":"2023.8.30 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461590","version":"1","longName":"Surgery Elements","context":"NCIP"}]},{"publicId":"3886759","version":"1","longName":"Surgery Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902142","version":"1","longName":"Surgery","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Singularity","type":"Preferred Question Text","description":"Tumor Singularity","url":null,"context":"BOLD"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CCB812A5-378F-45C6-E040-BB89AD433803","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"REEVESD","dateModified":"2016-05-17","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}